Loading: 100%
CareDx, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 161 (as per Q2 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker CDNAno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,01,53,04,56,0
datesClosing price (adj.)
13.10.20175.52
11.10.20175.90
04.10.20174.41
27.09.20174.12
20.09.20172.79
13.09.20172.68
06.09.20172.85
30.08.20172.97
23.08.20172.15
16.08.20171.83
09.08.20171.42
02.08.20171.49
26.07.20171.32
19.07.20171.32
12.07.20171.25
05.07.20171.09
27.06.20171.10
20.06.20171.09
13.06.20171.03
06.06.20171.10
30.05.20171.01
23.05.20171.05
16.05.20170.95
09.05.20171.03
02.05.20170.88
25.04.20170.99
18.04.20171.05
11.04.20171.25
04.04.20171.35
28.03.20171.55
21.03.20171.55
14.03.20172.15
07.03.20172.35
28.02.20172.10
21.02.20172.25
14.02.20172.30
07.02.20172.30
31.01.20172.40
24.01.20172.45
17.01.20172.60
10.01.20172.65
03.01.20172.30
27.12.20162.65
19.12.20162.95
12.12.20163.05
05.12.20163.05
28.11.20163.75
21.11.20163.00
14.11.20164.00
07.11.20163.75
31.10.20163.65
24.10.20163.87
17.10.20163.85
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
5.52n/a
Market Capitalisation
in million USD
105n/a
Enterprise Value
in million USD
116n/a
Common Shares Outstanding
as per Jul 29, 2016
18,976,343n/a
Preferred Shares Outstanding
as per Jul 29, 2016
n/a
Average Basic Shares Outstanding
TTM
12,332,874n/a
Average Diluted Shares Outstanding
TTM
11,860,885n/a
Index Membership
n/a
Business Summary
CareDx Inc is a commercial stage company. The Company develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient\'s lifetime.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 31n/a
Gross Profit 17n/a
Operating Income -22n/a
EBITDA -20n/a
Net Profit -28n/a
Balance Sheet
Cash and Cash Equivalents 17n/a
Receivables 5n/a
Total Current Assets 32n/a
PP&E 3n/a
Total Assets 100n/a
Accounts Payable 3n/a
Current Debt 18n/a
Total Current Liabilities 38n/a
Long-Term Debt 10n/a
Total Liabilities 68n/a
Total Equity 33n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital 2n/a
Operating Cash Flow -19n/a
Net Change in PP&E and Intangibles -1n/a
Investing Cash Flow -21n/a
Dividends Paid 0n/a
Financing Cash Flow 21n/a
Total Change in Cash -20n/a
Free Cash Flow -18n/a
Profitability Ratios
Gross Margin 55.8%n/a
Operating Margin -69.2%n/a
Net Profit Margin -91.6%n/a
Return on Equity -87.6%n/a
Return on Assets -28.4%n/a
Per Share Figures
Basic EPS -2.31n/a
Diluted EPS n/a
Sales per Share 2.52n/a
Book Value per Share 2.59n/a
FCF per Share -1.45n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -2.39n/a
Price to Sales Ratio 2.19n/a
Price to Book Value 2.09n/a
Price to Free Cash Flow -3.81n/a
Valuation Metrics
EV/EBITDA -5.83n/a
EV/Sales 3.74n/a
Book to Market Value 0.31n/a
Other Ratios
Current Ratio 84.9%n/a
Liabilities to Equity Ratio 209.0%n/a
Debt to Assets Ratio 28.1%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue
20
22
27
28
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-8
-9
-9
-10
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
13
13
19
18
Other Operating Income
0
0
0
0
Operating Expenses
-15
-14
-19
-30
Selling, General & Administrative
-10
-11
-15
-21
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
-5
-3
-4
-9
Depreciation & Amortization
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
-2
-1
0
-12
Non-Operating Income (Loss)
-3
-3
-2
-2
Interest Expense, net
-3
-2
-2
-2
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
0
-1
0
0
Pretax Income (Loss), Adjusted
-5
-4
-2
-14
Abnormal Gains (Losses)
0
0
1
0
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
-5
-4
-1
-14
Income Tax (Expense) Benefit, net
0
0
2
0
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
-5
-4
1
-14
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
-5
-4
1
-14
Minority Interest
0
0
0
0
Net Income
-5
-4
1
-14
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
-5
-4
1
-14
Remarks
restated on Mar 31, 2015 n/a
calculated values,
restated on Mar 29, 2016 n/a
calculated values,
restated on Mar 29, 2016 n/a
calculated values,
restated on Mar 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
5
36
30
Cash & Cash Equivalents
n/a
5
36
30
Short Term Investments
n/a
0
0
0
Accounts & Notes Receivable
n/a
2
3
2
Accounts Receivable, Net
n/a
2
3
2
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
1
1
1
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
0
1
1
Prepaid Expenses
n/a
0
1
1
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
Total Current Assets
n/a
8
40
34
Property, Plant & Equipment, Net
n/a
2
2
2
Property, Plant & Equipment
n/a
0
0
0
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
0
19
19
Intangible Assets
n/a
0
7
7
Goodwill
n/a
0
12
12
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
Total Noncurrent Assets
n/a
2
21
21
Total Assets
n/a
10
61
56
Liabilities and owners' equity
Payables & Accruals
n/a
3 3052000
5 4669000
7 7144000
Accounts Payable
n/a
1 618000
1 1128000
2 1644000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
2 2434000
4 3541000
6 5500000
Short Term Debt
n/a
4 4461000
6 5961000
3 2866000
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 80000
1 505000
0 142000
Deferred Revenue
n/a
0 80000
1 505000
0 142000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
Total Current Liabilities
n/a
8 7593000
11 11135000
10 10152000
Long Term Debt
n/a
11 10914000
5 5451000
13 12887000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
7 6837000
3 3257000
3 3105000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
2 1623000
0 471000
1 703000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
5 5214000
3 2786000
2 2402000
Total Noncurrent Liabilities
n/a
18 17751000
9 8708000
16 15992000
Total Liabilities
n/a
25 25344000
20 19843000
26 26144000
Preferred Equity
n/a
135 135202000
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
9 9483000
201 200673000
203 202576000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
-160 -160156000
-159 -159375000
-173 -173082000
Other Equity
n/a
0 0
0 0
0 0
Equity Before Minority Interest
n/a
-15 -15471000
41 41298000
29 29494000
Minority Interest
n/a
0 0
0 0
0 0
Total Equity
n/a
-15 -15471000
41 41298000
29 29494000
Total Liabilities & Equity
n/a
10 9873000
61 61141000
56 55638000
Remarks restated on n/a restated on Mar 31, 2015 n/a restated on Mar 29, 2016 n/a restated on Aug 22, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net Income/Starting Line
-5
-4
1
-14
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
1
1
1
1
Non-Cash Items
1
1
-2
1
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
2
1
-2
2
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
-2
-1
-3
-10
Change in Fixed Assets & Intangibles
0
0
-1
-1
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
-2
0
0
0
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-1
0
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
2
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
1
0
-1
-1
Dividends Paid
0
0
0
0
Cash From (Repayment of) Debt
5
0
36
4
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
Increase in Capital Stock
0
0
0
0
Decrease in Capital Stock
0
0
0
0
Other Financing Activities
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
5
0
36
4
Net Cash Before Disc. Operations and FX
3
-1
31
-7
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
3
-1
31
-7
Effect of Foreign Exchange Rates
0
0
0
0
Net Changes in Cash
3
-1
31
-7
Remarks
restated on Mar 31, 2015 n/a
calculated values,
restated on Mar 29, 2016 n/a
calculated values,
restated on Mar 29, 2016 n/a
calculated values,
restated on Mar 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo